Related Experiment Videos
Congenital heart disease: current indications for antithrombotic therapy in pediatric patients
1Division of Pediatric Cardiology, Oregon Health Sciences University, 707 SW Gaines Road, CDRC-P, Portland, OR 97201, USA. rellerm@ohsu.edu
Current Cardiology Reports
|January 5, 2001
Insights
This review covers antithrombotic and anti-platelet therapies for pediatric patients with congenital heart disease. It details current medication use, dosages, and indications for treatment.
Area of Science:
- Cardiology
- Pediatric Medicine
- Pharmacology
Background:
- Congenital heart disease (CHD) presents unique challenges for managing thrombotic risk in pediatric populations.
- Antithrombotic therapy is crucial for preventing thromboembolic events in these vulnerable patients.
Purpose of the Study:
- To provide a comprehensive overview of current antithrombotic strategies, including anti-platelet agents, in pediatric patients with CHD.
- To summarize recommended medication classes, dosages, and clinical indications for antithrombotic therapy in this cohort.
Main Methods:
- Literature review of current clinical practice guidelines and relevant research.
- Synthesis of data on commonly used antithrombotic medications and their pediatric dosing.
- Analysis of established indications for initiating and continuing therapy.
Main Results:
- Detailed review of anti-platelet agents (e.g., aspirin, clopidogrel) and anticoagulant options.
- Emphasis on age-appropriate dosing and administration routes for pediatric use.
- Discussion of specific indications based on CHD type and patient factors.
Conclusions:
- Current antithrombotic therapy in pediatric CHD requires careful consideration of medication, dose, and indication.
- Standardized guidelines and further research are needed to optimize treatment outcomes.
- Effective management of thrombotic risk is integral to improving long-term prognosis in pediatric CHD.
Abstract:
This report reviews the current status of antithrombotic therapy, including anti-platelet therapy, in pediatric patients with congenital heart disease. The current medications utilized and dose recommendations are emphasized, and indications for their use are reviewed.